BioSpace News Archive

Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced that management will be attending the following upcoming investor conferences

Marinus Pharmaceuticals, Inc. announced that the Board of Directors of Marinus granted non-qualified stock options to purchase an aggregate of 60,000 shares of its common stock to new employees, with a grant date of February 5, 2020.

Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced the closing of its previously announced underwritten public offering of 10,925,000 shares of its common stock at a public offering price of $13.75 per share, which included the full exercise of the underwriters’ option to purchase up to an additional 1,425,000 shares of common stock.

Predictive Technology Group (OTC PINK: PRED) (“Predictive” or “The Company”), a leader in helping identify barriers that impact women’s health and build healthier families through its innovations to deliver personalized medicine, today announced financial results for the fiscal second quarter ended December 31, 2019 and provided a corporate update.

Teleflex Incorporated (NYSE: TFX), a global provider of medical technologies for critical care and surgery, has announced a worldwide voluntary recall of the COMFORT FLO® Humidification System.

Annual Report showcases year of advances, driven by $121.5 million in direct support and nearly $300 million in additional funding for T1D research

The global dental membrane and bone graft substitutes market was valued at ~US$ 620 mn in 2018, and is projected to expand at a high CAGR from 2019 to 2027.

Transparency Market Research (TMR) has published a new report titled, “Medical Sensors Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

Bionet America, Inc. announces the launch of the long awaited BMVet PRO Series of Veterinary specific multiparameter monitors.

Twirla® is a new non-daily, non-invasive contraceptive approved in the U.S.